STN: BL 125402/0
Proper Name: Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase
Tradename: HYQVIA
Manufacturer: Takeda Pharmaceuticals U.S.A., Inc.
Indication:

HYQVIA is an Immune Globulin Infusion 10% (Human) with a Recombinant Human Hyaluronidase (rHuPH20) indicated for the treatment of

  • Primary Immunodeficiency (PI) in adults and pediatric patients two years of age and older.
  • Maintenance therapy in adults with chronic inflammatory demyelinating polyneuropathy (CIDP).

Product Information

Supporting Documents

  • Content current as of:

    01/16/2024

Source

Clinical :: Oncology :: Nuclear :: Geriatric :: Regulatory :: Technology :: Consulting

"My passion is helping businesses, small and large, perform at their best." - Felicia Udoji-Eddings, Pharm.D.

Dr. Felicia Udoji-Eddings is the Founder and CEO of The Health Pals Company, a vertically integrated Healthcare System. As an experienced Clinical Pharmacy Leader, Pharmacy Consultant, Healthcare Executive, and Licensed Pharmacy Practitioner with deep backgrounds in Information Technology (IT), Scientific Research, and Business Management. Dr. Udoji-Eddings has a strong track record of exceptional performance in different business environments. A skilled Business Strategist, Dr. Udoji-Eddings has tackled complex problems and helped several organizations refocus their strategy in tough economic times. As a highly motivated and proactive individual, Felicia enjoys working with teams, in various capacities, to facilitate positive outcomes.